Cargando…
Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236623/ https://www.ncbi.nlm.nih.gov/pubmed/36929591 http://dx.doi.org/10.1111/cas.15784 |
| _version_ | 1785052977380196352 |
|---|---|
| author | Miyazaki, Kana Sakai, Rika Iwaki, Noriko Yamamoto, Go Murayama, Kayoko Nishikori, Momoko Sunami, Kazutaka Yoshida, Isao Yano, Hiroki Takahashi, Naoki Okamoto, Akinao Munemoto, Saori Sawazaki, Aiko Suehiro, Youko Fukuhara, Noriko Wake, Atsushi Arai, Ayako Masaki, Yasufumi Toyama, Kohtaro Yokoyama, Akihiro Tsunemine, Hiroko Hasegawa, Yuichi Matsumoto, Kenji Yamada, Tomomi Nishimura, Yuki Tamaru, Satoshi Asano, Naoko Miyawaki, Kohta Izutsu, Koji Kinoshita, Tomohiro Suzuki, Ritsuro Ohshima, Koichi Kato, Koji Katayama, Naoyuki Yamaguchi, Motoko |
| author_facet | Miyazaki, Kana Sakai, Rika Iwaki, Noriko Yamamoto, Go Murayama, Kayoko Nishikori, Momoko Sunami, Kazutaka Yoshida, Isao Yano, Hiroki Takahashi, Naoki Okamoto, Akinao Munemoto, Saori Sawazaki, Aiko Suehiro, Youko Fukuhara, Noriko Wake, Atsushi Arai, Ayako Masaki, Yasufumi Toyama, Kohtaro Yokoyama, Akihiro Tsunemine, Hiroko Hasegawa, Yuichi Matsumoto, Kenji Yamada, Tomomi Nishimura, Yuki Tamaru, Satoshi Asano, Naoko Miyawaki, Kohta Izutsu, Koji Kinoshita, Tomohiro Suzuki, Ritsuro Ohshima, Koichi Kato, Koji Katayama, Naoyuki Yamaguchi, Motoko |
| author_sort | Miyazaki, Kana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10236623 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102366232023-06-03 Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL Miyazaki, Kana Sakai, Rika Iwaki, Noriko Yamamoto, Go Murayama, Kayoko Nishikori, Momoko Sunami, Kazutaka Yoshida, Isao Yano, Hiroki Takahashi, Naoki Okamoto, Akinao Munemoto, Saori Sawazaki, Aiko Suehiro, Youko Fukuhara, Noriko Wake, Atsushi Arai, Ayako Masaki, Yasufumi Toyama, Kohtaro Yokoyama, Akihiro Tsunemine, Hiroko Hasegawa, Yuichi Matsumoto, Kenji Yamada, Tomomi Nishimura, Yuki Tamaru, Satoshi Asano, Naoko Miyawaki, Kohta Izutsu, Koji Kinoshita, Tomohiro Suzuki, Ritsuro Ohshima, Koichi Kato, Koji Katayama, Naoyuki Yamaguchi, Motoko Cancer Sci LETTER TO THE EDITOR John Wiley and Sons Inc. 2023-03-16 /pmc/articles/PMC10236623/ /pubmed/36929591 http://dx.doi.org/10.1111/cas.15784 Text en © 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | LETTER TO THE EDITOR Miyazaki, Kana Sakai, Rika Iwaki, Noriko Yamamoto, Go Murayama, Kayoko Nishikori, Momoko Sunami, Kazutaka Yoshida, Isao Yano, Hiroki Takahashi, Naoki Okamoto, Akinao Munemoto, Saori Sawazaki, Aiko Suehiro, Youko Fukuhara, Noriko Wake, Atsushi Arai, Ayako Masaki, Yasufumi Toyama, Kohtaro Yokoyama, Akihiro Tsunemine, Hiroko Hasegawa, Yuichi Matsumoto, Kenji Yamada, Tomomi Nishimura, Yuki Tamaru, Satoshi Asano, Naoko Miyawaki, Kohta Izutsu, Koji Kinoshita, Tomohiro Suzuki, Ritsuro Ohshima, Koichi Kato, Koji Katayama, Naoyuki Yamaguchi, Motoko Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL |
| title | Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
|
| title_full | Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
|
| title_fullStr | Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
|
| title_full_unstemmed | Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
|
| title_short | Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
|
| title_sort | five‐year follow‐up of a phase ii study of da‐epoch‐r with high‐dose mtx in cd5‐positive dlbcl |
| topic | LETTER TO THE EDITOR |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236623/ https://www.ncbi.nlm.nih.gov/pubmed/36929591 http://dx.doi.org/10.1111/cas.15784 |
| work_keys_str_mv | AT miyazakikana fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT sakairika fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT iwakinoriko fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT yamamotogo fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT murayamakayoko fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT nishikorimomoko fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT sunamikazutaka fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT yoshidaisao fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT yanohiroki fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT takahashinaoki fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT okamotoakinao fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT munemotosaori fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT sawazakiaiko fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT suehiroyouko fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT fukuharanoriko fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT wakeatsushi fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT araiayako fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT masakiyasufumi fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT toyamakohtaro fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT yokoyamaakihiro fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT tsuneminehiroko fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT hasegawayuichi fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT matsumotokenji fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT yamadatomomi fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT nishimurayuki fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT tamarusatoshi fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT asanonaoko fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT miyawakikohta fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT izutsukoji fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT kinoshitatomohiro fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT suzukiritsuro fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT ohshimakoichi fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT katokoji fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT katayamanaoyuki fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl AT yamaguchimotoko fiveyearfollowupofaphaseiistudyofdaepochrwithhighdosemtxincd5positivedlbcl |